Clinical Trial Update: Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating sedation and physiological effects of intranasal dexmedetomidine in patients with severe COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Dayton VA Medical Center | Conditions: COPD, Sedation | Phase 4 | Status: COMPLETED